Podcast Episodes

Back to Search
Biomarkers alone don’t mean Alzheimer’s disease is present, Elizabeth Tracey reports

Will an FDA cleared blood test for Alzheimer’s disease ease or complicate diagnosis? Clearly in approving the test the FDA hopes for the former, yet …

7 months, 1 week ago

Short Long
View Episode
If you get a positive result on the new blood test for Alzheimer’s disease, what does that mean? Elizabeth Tracey reports

Positive results on the newly FDA cleared blood test for Alzheimer’s disease don’t necessarily mean you have the disease. That’s according to blood b…

7 months, 1 week ago

Short Long
View Episode
Who is a candidate for the new blood test for Alzheimer’s disease? Elizabeth Tracey reports

The FDA has just cleared a blood test to help make the diagnosis of Alzheimer’s disease, which otherwise may require some fairly invasive methods. Bl…

7 months, 1 week ago

Short Long
View Episode
What’s the basis of the new blood test to screen for Alzheimer’s disease? Elizabeth Tracey reports

A blood test to screen for proteins related to Alzheimer’s disease has been cleared by the FDA, and it’s designed for people who are older than 55 ye…

7 months, 1 week ago

Short Long
View Episode
A protein that’s made in your brain at night helps you remember things, Elizabeth Tracey reports

NPTX2 is a protein that’s pivotal for helping your brain decide to remember certain things and forget others, and when levels of it decline it sugges…

7 months, 2 weeks ago

Short Long
View Episode
How do neurodegenerative diseases begin? Elizabeth Tracey reports

Many theories on how brain disorders like Alzheimer’s disease begin point to proteins called amyloid beta and tau as accumulating and disrupting the …

7 months, 2 weeks ago

Short Long
View Episode
A change in a protein in the brain signals possible neurocognitive disorders, Elizabeth Tracey reports

You probably know how complex your brain function is, relying on a delicately balanced system full of proteins that act as signals and specialized ne…

7 months, 2 weeks ago

Short Long
View Episode
Accurately predicting who’s at risk to develop Alzheimer’s disease may now be easier, Elizabeth Tracey reports

NPTX2 is the abbreviation for a protein found in the brain that may allow much more accurate prognosis of who’s at risk for developing neurocognitive…

7 months, 2 weeks ago

Short Long
View Episode
What can proteins in the blood and elsewhere teach us about developing dementia? Elizabeth Tracey reports

Proteins known as tau and beta amyloid have been part of the dialogue on Alzheimer’s disease development for many years, with methods to measure them…

7 months, 2 weeks ago

Short Long
View Episode
Sickle cell disease should be treated with a half-matched donor approach, Elizabeth Tracey reports

Sickle cell disease was thought to be cured using gene therapy, but longer term follow up reveals that while the condition improves many are not cure…

7 months, 3 weeks ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us